These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19536079)

  • 1. The clinical course of ANCA small-vessel vasculitis on chronic dialysis.
    Lionaki S; Hogan SL; Jennette CE; Hu Y; Hamra JB; Jennette JC; Falk RJ; Nachman PH
    Kidney Int; 2009 Sep; 76(6):644-51. PubMed ID: 19536079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.
    Lee SW; Yu MY; Baek SH; Ahn SY; Kim S; Na KY; Chae DW; Chin HJ
    J Korean Med Sci; 2016 Apr; 31(4):542-6. PubMed ID: 27051237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression.
    Gera M; Griffin MD; Specks U; Leung N; Stegall MD; Fervenza FC
    Kidney Int; 2007 Jun; 71(12):1296-301. PubMed ID: 17410100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation.
    Elmedhem A; Adu D; Savage CO
    Nephrol Dial Transplant; 2003 May; 18(5):1001-4. PubMed ID: 12686678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
    Hogan SL; Falk RJ; Chin H; Cai J; Jennette CE; Jennette JC; Nachman PH
    Ann Intern Med; 2005 Nov; 143(9):621-31. PubMed ID: 16263884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis.
    Weidanz F; Day CJ; Hewins P; Savage CO; Harper L
    Am J Kidney Dis; 2007 Jul; 50(1):36-46. PubMed ID: 17591523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.
    Slot MC; Tervaert JW; Franssen CF; Stegeman CA
    Kidney Int; 2003 Feb; 63(2):670-7. PubMed ID: 12631133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement.
    Rihova Z; Jancova E; Merta M; Rysava R; Reiterova J; Zabka J; Tesar V
    Kidney Blood Press Res; 2005; 28(3):144-52. PubMed ID: 15908752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients.
    Kaplan-Pavlovcic S; Cerk K; Kveder R; Lindic J; Vizjak A
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v5-7. PubMed ID: 12817057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study.
    Kim JY; Choi H; Kim MK; Lee SB; Park YB; Lee SW
    Rheumatol Int; 2019 Nov; 39(11):1927-1936. PubMed ID: 31372719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis.
    Chen YX; Zhang W; Chen XN; Ni LY; Shen PY; Wang WM; Chen N
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S5-10. PubMed ID: 24480250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Allen A; Pusey C; Gaskin G
    J Am Soc Nephrol; 1998 Jul; 9(7):1258-63. PubMed ID: 9644636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
    Booth AD; Almond MK; Burns A; Ellis P; Gaskin G; Neild GH; Plaisance M; Pusey CD; Jayne DR;
    Am J Kidney Dis; 2003 Apr; 41(4):776-84. PubMed ID: 12666064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory genotype of interleukin-1 and interleukin-1 receptor antagonist is associated with ESRD in proteinase 3-ANCA vasculitis patients.
    Borgmann S; Endisch G; Hacker UT; Song BS; Fricke H
    Am J Kidney Dis; 2003 May; 41(5):933-42. PubMed ID: 12722027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients.
    Hasegawa M; Hattori K; Sugiyama S; Asada H; Yamashita H; Takahashi K; Hayashi H; Koide S; Sato W; Yuzawa Y
    Mod Rheumatol; 2016; 26(1):110-4. PubMed ID: 25967129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.
    Stangou M; Asimaki A; Bamichas G; Christidou F; Zoumbaridis N; Natse T; Galanis N; Christaki P; Patakas D; Sombolos K
    J Nephrol; 2005; 18(1):35-44. PubMed ID: 15772921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.